相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Multi-omics of human plasma reveals molecular features of dysregulated inflammation and accelerated aging in schizophrenia
Anaamika Campeau et al.
MOLECULAR PSYCHIATRY (2022)
Altered Metabolism in Alzheimer Disease Brain: Role of Oxidative Stress
Nicole G. Rummel et al.
ANTIOXIDANTS & REDOX SIGNALING (2022)
Systematic Review and Meta-Analysis of Mass Spectrometry Proteomics Applied to Human Peripheral Fluids to Assess Potential Biomarkers of Schizophrenia
Joao E. Rodrigues et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
BET-ting on histone proteomics in schizophrenia
Marija Kundakovic
TRENDS IN NEUROSCIENCES (2022)
Lower levels of tubulin alpha 1b in the frontal pole in schizophrenia supports a role for changed cytoskeletal dynamics in the aetiology of the disorder
Megan Snelleksz et al.
PSYCHIATRY RESEARCH (2021)
Identification of bioactive metabolites in human iPSC-derived dopaminergic neurons with PARK2 mutation: Altered mitochondrial and energy metabolism
Justyna Okarmus et al.
STEM CELL REPORTS (2021)
Dopamine Receptor Subtypes, Physiology and Pharmacology: New Ligands and Concepts in Schizophrenia
Jean Claude Martel et al.
FRONTIERS IN PHARMACOLOGY (2020)
SNARE Complex Dysfunction: A Unifying Hypothesis for Schizophrenia
Sara Marie Katrancha et al.
BIOLOGICAL PSYCHIATRY (2015)
Increased SNARE Protein-Protein Interactions in Orbitofrontal and Anterior Cingulate Cortices in Schizophrenia
Alfredo Ramos-Miguel et al.
BIOLOGICAL PSYCHIATRY (2015)
Cell type- and brain region-resolved mouse brain proteome
Kirti Sharma et al.
NATURE NEUROSCIENCE (2015)
Transcriptome sequencing and genome-wide association analyses reveal lysosomal function and actin cytoskeleton remodeling in schizophrenia and bipolar disorder
Z. Zhao et al.
MOLECULAR PSYCHIATRY (2015)
The Sirtuin-2 Inhibitor AK7 Is Neuroprotective in Models of Parkinson's Disease but Not Amyotrophic Lateral Sclerosis and Cerebral Ischemia
Xiqun Chen et al.
PLOS ONE (2015)
Neuromelanin Magnetic Resonance Imaging Reveals Increased Dopaminergic Neuron Activity in the Substantia Nigra of Patients with Schizophrenia
Yoshiyuki Watanabe et al.
PLOS ONE (2014)
Dopaminergic basis of salience dysregulation in psychosis
Toby T. Winton-Brown et al.
TRENDS IN NEUROSCIENCES (2014)
ERK1/2 regulates SIRT2 deacetylase activity
You Hee Choi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)
Impaired Prefrontal-Basal Ganglia Functional Connectivity and Substantia Nigra Hyperactivity in Schizophrenia
Jong H. Yoon et al.
BIOLOGICAL PSYCHIATRY (2013)
Midbrain dopamine function in schizophrenia and depression: a post-mortem and positron emission tomographic imaging study
Oliver D. Howes et al.
BRAIN (2013)
Large-scale gene function analysis with the PANTHER classification system
Huaiyu Mi et al.
NATURE PROTOCOLS (2013)
Dysfunction of the Ubiquitin Proteasome and Ubiquitin-Like Systems in Schizophrenia
Maria D. Rubio et al.
NEUROPSYCHOPHARMACOLOGY (2013)
Suppression of CLIC4/mtCLIC enhances hydrogen peroxide-induced apoptosis in C6 glioma cells
Ye Xu et al.
ONCOLOGY REPORTS (2013)
Increased proteome coverage by combining PAGE and peptide isoelectric focusing: Comparative study of gel-based separation approaches
Ilian Atanassov et al.
PROTEOMICS (2013)
Phosphoproteome profiling of substantia nigra and cortex regions of Alzheimer's disease patients
Saadia Zahid et al.
JOURNAL OF NEUROCHEMISTRY (2012)
Expression analysis of dopaminergic neurons in Parkinson's disease and aging links transcriptional dysregulation of energy metabolism to cell death
Matthias Elstner et al.
ACTA NEUROPATHOLOGICA (2011)
The Role of Energy Metabolism Dysfunction and Oxidative Stress in Schizophrenia Revealed by Proteomics
Daniel Martins-de-Souza et al.
ANTIOXIDANTS & REDOX SIGNALING (2011)
The Neuroproteomics of Schizophrenia
Jane A. English et al.
BIOLOGICAL PSYCHIATRY (2011)
Profiles of DARPP-32 in the insular cortex with schizophrenia: A postmortem brain study
Keisuke Nishiura et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2011)
The environment and susceptibility to schizophrenia
Alan S. Brown
PROGRESS IN NEUROBIOLOGY (2011)
Oxidatively Modified Glyceraldehyde-3-Phosphate Dehydrogenase (GAPDH) and Alzheimer's Disease: Many Pathways to Neurodegeneration
D. Allan Butterfield et al.
JOURNAL OF ALZHEIMERS DISEASE (2010)
Proteome analysis of the thalamus and cerebrospinal fluid reveals glycolysis dysfunction and potential biomarkers candidates for schizophrenia
Daniel Martins-de-Souza et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2010)
Proteome analysis of schizophrenia brain tissue
Daniel Martins-De-Souza et al.
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY (2010)
Structural and Functional Brain Abnormalities in Schizophrenia
Katherine H. Karlsgodt et al.
CURRENT DIRECTIONS IN PSYCHOLOGICAL SCIENCE (2010)
Proteome analysis of schizophrenia patients Wernicke's area reveals an energy metabolism dysregulation
Daniel Martins-de-Souza et al.
BMC PSYCHIATRY (2009)
Redox dysregulation, neurodevelopment, and schizophrenia
Kim Q. Do et al.
CURRENT OPINION IN NEUROBIOLOGY (2009)
Prefrontal cortex shotgun proteome analysis reveals altered calcium homeostasis and immune system imbalance in schizophrenia
Daniel Martins-de-Souza et al.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2009)
Proteomic analysis of dorsolateral prefrontal cortex indicates the involvement of cytoskeleton, oligodendrocyte, energy metabolism and new potential markers in schizophrenia
Daniel Martins-de-Souza et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2009)
Protein expression overlap: more important than which proteins change in expression?
Claus Zabel et al.
EXPERT REVIEW OF PROTEOMICS (2008)
iTRAQ Analysis of Complex Proteome Alterations in 3xTgAD Alzheimer's Mice: Understanding the Interface between Physiology and Disease
Bronwen Martin et al.
PLOS ONE (2008)
Schizophrenia, Just the Facts What we know in 2008. 2. Epidemiology and etiology
Rajiv Tandon et al.
SCHIZOPHRENIA RESEARCH (2008)
Prenatal infection as a risk factor for schizophrenia
AS Brown
SCHIZOPHRENIA BULLETIN (2006)
Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress
S Prabakaran et al.
MOLECULAR PSYCHIATRY (2004)
The hippocampus in schizophrenia: a review of the neuropathological evidence and its pathophysiological implications
PJ Harrison
PSYCHOPHARMACOLOGY (2004)
A statistical model for identifying proteins by tandem mass spectrometry
AI Nesvizhskii et al.
ANALYTICAL CHEMISTRY (2003)
分享论文
